2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Prostatic Neoplasms
25
Carcinoma, Non-Small-Cell Lung
13
Breast Neoplasms
13
Neoplasms
12
Colonic Neoplasms
9
Uterine Cervical Neoplasms
7
Lung Neoplasms
6
Colorectal Neoplasms
6
Urinary Bladder Neoplasms
5
Melanoma
5
Leukemia, Myeloid, Acute
5
Carcinoma, Renal Cell
5
Uterine Cervical Dysplasia
4
Lymphoma, Large B-Cell, Diffuse
4
Esophageal Neoplasms
4
Brain Neoplasms
4
Thrombocythemia, Essential
3
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Polycythemia Vera
3
Papillomavirus Infections
3
Oropharyngeal Neoplasms
3
Neuroblastoma
3
Mouth Neoplasms
3
Liver Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Glioma
3
Gallbladder Neoplasms
3
Carcinoma, Hepatocellular
3
Interventions
Paclitaxel
2
Carboplatin
2
selinexor
1
pazopanib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Pregnancy Tests
1
Naproxen
1
Human Papillomavirus DNA Tests
1
GX-188 vaccine
1
Filgrastim
1
Educational Status
1
Drug Therapy
1
Colposcopy
1
Biopsy
1
Anesthesia, General
1
Acetic Acid
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Diseases
×
Watchful Waiting
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled